跳至主要内容
临床试验/NCT07108179
NCT07108179Enrolling By Invitation不适用

Continuous Glucose Monitoring System: Accuracy and Prognostic Value in Critically Ill Patients

Sinocare1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2025年3月4日最近更新:

试验速览

阶段
不适用
状态
Enrolling By Invitation
发起方
Sinocare
入组人数
120
试验地点
1
主要终点
Accuracy

研究概览

简要总结

Whether diabetic or non-diabetic patients, blood glucose management during ICU hospitalization is essential. This study aims to evaluate the accuracy of the iCan Continuous Glucose Monitoring (CGM) System for detecting blood glucose levels in ICU patients, as well as its value in prognostic evaluation, to provide reference for blood glucose management in critically ill patients.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 18 years; gender not limited.
  • Expected ICU (Intensive Care Unit) stay ≥ 48 hours.
  • Patients requiring frequent blood gas monitoring in the ICU.

排除标准

  • The patient or their family refuses to use CGM for blood glucose monitoring.
  • Patients with adverse skin conditions (such as rash, active inflammation, etc.) in the device placement area, or those requiring emergency surgical intervention in that area.
  • Patients who need to undergo computed tomography (CT), X-ray, or magnetic resonance imaging (MRI) scans on the device placement area during the study period.

结局指标

主要结局

Accuracy

时间窗: Up to eight days

"Comparison between arterial blood gas analysis glucose values and CGM values at the same time"

次要结局

未报告次要终点

研究者

发起方
Sinocare
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验